(Q34060970)

30 July 2017

1 reference

title

Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology? (English)

1 reference

30 July 2017

1 reference

Fehm HL

1

1 reference

30 July 2017

Perras B

2

1 reference

30 July 2017

Smolnik R

3

1 reference

30 July 2017

Kern W

4

1 reference

30 July 2017

Born J

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

European Journal of Pharmacology

30 July 2017

1 reference

30 July 2017

405

1 reference

30 July 2017

1-3

1 reference

30 July 2017

43-54

1 reference

Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Insulin receptor substrate-1 (IRS-1) expression in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

The behaviorally active peptide ACTH 4-10: measurement in plasma and pharmacokinetics in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

ACTH and attention in humans: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Vasopressin-deficient rats show a reduced amplitude of the circadian sleep rhythm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Sleep deficits in rats with hereditary diabetes insipidus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Neuropeptides: animal behaviour and human psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Effects of pulsatile cortisol infusion on sleep-EEG and nocturnal growth hormone release in healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Intranasal insulin. Clinical pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Central nervous system effects of intranasally administered insulin during euglycemia in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist or vasoactive intestinal polypeptide on circadian sleep-wake rhythm in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Effects of hyperinsulinemia on local cerebral insulin binding and glucose utilization in normoglycemic awake rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

The effect of vasopressin on memory in the healthy elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Memory search and visual spatial attention: an event-related brain potential analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Sleep and signs of attention during 3 months of intranasal vasopressin: a pilot study in two elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Geriatrics: sleep disorders and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Differentiation of hypoglycaemia induced cognitive impairments. An electrophysiological approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Does DGAVP influence memory, attention and mood in young healthy men?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Ageing of the human hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Isolation of specific interference processing in the Stroop task: PET activation studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Action of lysine-vasopressin on human electroencephalographic activity. Night sleep pattern, auditory evoked potential, contingent negative variation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Neuropeptides: Effects on paradoxical sleep and theta rhythm in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

Processing negativity: an evoked-potential reflection of selective attention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900540-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00540-9

1 reference

30 July 2017

1 reference